1,631 results on '"Desai, Nihar"'
Search Results
52. Imagine Quality Heart Failure Care, I Wonder If You Can
53. Epidemiology and risk factors for hyperkalaemia in heart failure
54. Bonded Repairs of Composite Panels Representative of Wing Structure
55. Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm
56. Forgone Medical Care Associated With Increased Health Care Costs Among the U.S. Heart Failure Population
57. Longitudinal Outcomes Associated With Non-Evidence-Based Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries (From the National Cardiovascular Data Registry)
58. Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes: Insights From the EMPA-REG OUTCOME Trial
59. Intercountry Differences in Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure
60. Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States
61. REVeAL-HF: Design and Rationale of a Pragmatic Randomized Controlled Trial Embedded Within Routine Clinical Practice
62. Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy
63. Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association
64. Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry)
65. Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial
66. Age Differences in Hospital Mortality for Acute Myocardial Infarction: Implications for Hospital Profiling.
67. Socio-Economic Burden of Myocardial Infarction Among Cancer Patients
68. Epidemiology and risk factors for hyperkalaemia in heart failure
69. Abstract 13439: Trends in Spending for P2Y12 Inhibitors by Medicare and Medicaid
70. Abstract 11481: Healthcare Resource Use, Early Benefit and Cost for North American Patients With HFrEF Most Likely to Benefit from Omecamtiv Mecarbil
71. Abstract 10851: A Randomized Study to Compare LDL-C-Lowering Effects of Inclisiran With Usual Care vs Usual Care Alone in Patients With Recent Hospitalization for an Acute Coronary Syndrome: Rationale and Design of the VICTORION-INCEPTION Trial
72. Abstract 9496: Association Between Oral Anticoagulant Type and Hospital Readmission Rates Following Myocardial Infarction With Percutaneous Coronary Intervention in Patients With Nonvalvular Atrial Fibrillation
73. Physician variation in the de-adoption of ineffective statin and fibrate therapy
74. Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation
75. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation
76. Sex Differences in Patients Receiving Left Ventricular Assist Devices for End-Stage Heart Failure
77. Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort
78. Psychiatric Comorbidity and Outcomes After Left Ventricular Assist Device Implantation for End-Stage Heart Failure
79. Association of cardiovascular risk factor profile and financial hardship from medical bills among non-elderly adults in the United States
80. Relationship Between Provider Experience and Cardiac Performance Measures in Outpatients (from the NCDR)
81. Machine Learning Prediction of Mortality and Hospitalization in Heart Failure With Preserved Ejection Fraction
82. Optimizing Care Delivery in Patients with Chronic Kidney Disease in the United States: Proceedings of a Multidisciplinary Roundtable Discussion and Literature Review
83. The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally
84. Approval, Evidence, and “Off-Label” Device Utilization: The Patent Foramen Ovale Closure Story
85. Bundled Payments for Care Improvement and Quality of Care and Outcomes in Heart Failure
86. Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial
87. Managing the economic challenges in the treatment of heart failure
88. Clinical Outcomes After Left Ventricular Assist Device Implantation in Older Adults: An INTERMACS Analysis
89. National Trends in Incidence and Outcomes of Patients With Heart Failure Requiring Respiratory Support
90. Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Tafamidis in Cardiac Amyloidosis
91. Digoxin Use and Associated Adverse Events Among Older Adults
92. National Trends in Healthcare-Associated Infections for Five Common Cardiovascular Conditions
93. The Evolving Management of Aortic Valve Disease: 5-Year Trends in SAVR, TAVR, and Medical Therapy
94. Comfort Measures Only in Myocardial Infarction: Prevalence of This Status, Change Over Time, and Predictors From a Nationwide Study
95. Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)
96. Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications
97. Cardiovascular Toxicities of Androgen Deprivation Therapy
98. Late‐onset Pneumocystis jirovecii pneumonia post‐allogeneic stem cell transplantation after time‐dependent discontinuation of prophylaxis.
99. Serum Potassium and Mortality in High-Risk Patients: SPRINT
100. Physician Network Connections Associated With Faster De-Adoption of Dronedarone for Permanent Atrial Fibrillation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.